Bortezomib-associated late hepatitis B reactivation in a case of multiple myeloma.
Beysel
Selvihan
S
Yeğın
Zeynep Arzu
ZA
Yağci
Münci
M
D000970:Antineoplastic Agents / Q000009:adverse effects*; D001897:Boronic Acids / Q000009:adverse effects*; D000069286:Bortezomib; D006509:Hepatitis B / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D011719:Pyrazines / Q000009:adverse effects*; D012008:Recurrence
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib